Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index V

Vaccines
in COPD: Sec. 3, Ch. 53
effectiveness of: Sec. 1, Ch. 2
in heart failure: Sec. 3, Ch. 46
influenza: Sec. 3, Ch. 46; Sec. 3, Ch. 52
pneumococcal: Sec. 3, Ch. 52
Vagina
atrophy of: Sec. 1, Ch. 2
     estrogen therapy for: Sec. 3, Ch. 58; Sec. 3, Ch. 58
bleeding from: Sec. 3, Ch. 58
infection of: Sec. 3, Ch. 58
prolapse of: Sec. 3, Ch. 58; Sec. 3, Ch. 58
Vagus nerve
stimulation of
     abnormal heart rhythms: Sec. 3, Ch. 47
Valerian: Sec. 2, Ch. 7; Sec. 2, Ch. 7
Valsartan
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Valves
heart: (see Heart valves)
in veins: Sec. 3, Ch. 44; Sec. 3, Ch. 44
Vardenafil
in erectile dysfunction: Sec. 3, Ch. 59
Varicella-zoster virus infection: Sec. 3, Ch. 35 (see also Shingles [herpes zoster])
Varices
esophageal: Sec. 3, Ch. 49
Varicose veins: Sec. 3, Ch. 44
esophageal: Sec. 3, Ch. 49
Vascular dementia: Sec. 3, Ch. 27
Vasomotor rhinitis: Sec. 3, Ch. 38
Vasovagal attack (syncope): Sec. 3, Ch. 20; Sec. 3, Ch. 20
Veins: Sec. 3, Ch. 44
blood clots in: Sec. 3, Ch. 44
dilation of: Sec. 3, Ch. 44
spider: Sec. 3, Ch. 44
stripping of: Sec. 3, Ch. 44
inflammation of: Sec. 3, Ch. 44
valves of: Sec. 3, Ch. 44; Sec. 3, Ch. 44
varicose: Sec. 3, Ch. 44
     in myelofibrosis: Sec. 3, Ch. 49
Vena cava
inferior: Sec. 3, Ch. 44
superior: Sec. 3, Ch. 44
Venlafaxine: Sec. 3, Ch. 32
Venography
in clotting disorders: Sec. 3, Ch. 49
Venous insufficiency
chronic: Sec. 3, Ch. 35; Sec. 3, Ch. 44; Sec. 3, Ch. 44; Sec. 3, Ch. 49
Venous ulcers: Sec. 3, Ch. 35; Sec. 3, Ch. 44
Ventilation
mechanical
     in COPD: Sec. 3, Ch. 53
     in heart failure: Sec. 3, Ch. 46
Ventricles(heart): Sec. 3, Ch. 45; Sec. 3, Ch. 46
Ventricular fibrillation: Sec. 3, Ch. 47; Sec. 3, Ch. 47; Sec. 3, Ch. 47
Ventricular tachycardia: Sec. 3, Ch. 47
Ventricular tachycardiac: Sec. 3, Ch. 47
Verapamil
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in high blood pressure: Sec. 3, Ch. 43
urinary incontinence with: Sec. 3, Ch. 57
Verbal apraxia: Sec. 2, Ch. 13
Vertebrae: (see also Spine)
compression fracture of: Sec. 3, Ch. 22
degenerative disease of: Sec. 3, Ch. 20
osteoporosis of: Sec. 3, Ch. 22
Vertebrobasilar insufficiency: Sec. 3, Ch. 20
Vertebroplasty: Sec. 3, Ch. 23
Vertigo: Sec. 3, Ch. 20
benign positional: Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20
in Meniere's disease: Sec. 3, Ch. 20; Sec. 3, Ch. 20
in stroke: Sec. 3, Ch. 28
Vesicoenteric fistula: Sec. 3, Ch. 56; Sec. 3, Ch. 56
Vesicovaginal fistula: Sec. 3, Ch. 56; Sec. 3, Ch. 56
Vestibule
vulvar: Sec. 3, Ch. 58
Veterans Affairs: Sec. 4, Ch. 66
Viral infections
in COPD: Sec. 3, Ch. 53
laryngitis with: Sec. 3, Ch. 38
lung: Sec. 3, Ch. 52
rhinitis with: Sec. 3, Ch. 38
sinusitis with: Sec. 3, Ch. 38
Vision
aging-related changes in: Sec. 1, Ch. 2; Sec. 1, Ch. 2
double: Sec. 3, Ch. 36; Sec. 3, Ch. 42
driving and: Sec. 4, Ch. 62
impairment of: Sec. 3, Ch. 36; Sec. 3, Ch. 36
     in age-related macular degeneration: Sec. 3, Ch. 36
     aids for: Sec. 3 Ch. 36 [sidebar]
     cataracts and: Sec. 3, Ch. 36
     in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34
     dizziness and: Sec. 3, Ch. 20; Sec. 3, Ch. 20
     in occipital lobe stroke: Sec. 3, Ch. 36
     in progressive supranuclear palsy: Sec. 3, Ch. 30
     in stroke: Sec. 3, Ch. 28
     cataracts and: Sec. 3, Ch. 36
     in diabetes: Sec. 3, Ch. 36
     doctor-patient communication and: Sec. 2, Ch. 8
     in glaucoma: Sec. 3, Ch. 36
     information resources on: 882-993
     in ischemic optic neuropathy: Sec. 3, Ch. 36
     sleep disorders with: Sec. 3, Ch. 31
     ocular blood flow disruption and: Sec. 3, Ch. 36
     rehabilitation for: Sec. 2, Ch. 13
     with retinal emboli: Sec. 3, Ch. 36
     sudden (amaurosis fugax): Sec. 3, Ch. 36
     in stroke: Sec. 2, Ch. 13
     in temporal arteritis: Sec. 3, Ch. 42; Sec. 3, Ch. 42
loss of
     information resources on: 882-883
Vitamin A (retinol)
supplemental: Sec. 1 Ch. 1 [sidebar]
Vitamin B12 (cobalamin): Sec. 2, Ch. 5
in coronary artery disease: Sec. 3, Ch. 45
deficiency of: Sec. 3, Ch. 17; Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49
     dizziness in: Sec. 3, Ch. 20; Sec. 3, Ch. 20
     mental function in: Sec. 3 Ch. 27 [sidebar]
supplemental: Sec. 3, Ch. 49
Vitamin B6 (pyridoxine)
in coronary artery disease: Sec. 3, Ch. 45
deficiency of: Sec. 3, Ch. 49
Vitamin C (ascorbic acid)
antioxidant activity of: Sec. 1 Ch. 1 [sidebar]
deficiency of: Sec. 3, Ch. 17
Vitamin D: Sec. 2, Ch. 5
in bone maintenance: Sec. 3 Ch. 22 [sidebar]
in calcium metabolism: Sec. 1, Ch. 2
deficiency of: Sec. 2, Ch. 11; Sec. 3, Ch. 17; Sec. 3, Ch. 18; Sec. 3 Ch. 22 [sidebar]
Vitamin E
antioxidant activity of: Sec. 1 Ch. 1 [sidebar]
supplemental
     in dementia: Sec. 3, Ch. 27
Vitamin(s): Sec. 2, Ch. 5
deficiency of: Sec. 3, Ch. 17; Sec. 3, Ch. 17
in food: Sec. 2, Ch. 5
high doses of: Sec. 3, Ch. 17
Vitrectomy
in diabetic retinopathy: Sec. 3, Ch. 36
Vocal cords: Sec. 3, Ch. 38
atrophy of: Sec. 3, Ch. 38
inflammation of: Sec. 3, Ch. 38
paralysis of: Sec. 3, Ch. 38
spasms of: Sec. 3, Ch. 30
Voice box: (see Larynx)
Voice
age-related changes in: Sec. 3, Ch. 38
disorders of: Sec. 3, Ch. 38
Voiding: (see Urination)
Volunteering: Sec. 4, Ch. 61
information resources on: 889
Vomiting
abnormal heart rhythms with: Sec. 3, Ch. 47
in cancer: Sec. 3, Ch. 50
in terminal illness: Sec. 2, Ch. 16
Vulva
cancer of: Sec. 3, Ch. 51
pain in: Sec. 3, Ch. 58
skin disorders of: Sec. 3, Ch. 58
Vulvodynia: Sec. 3, Ch. 58
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.